Ostrand-Rosenberg S - Search Results

1

Animal models of tumor immunity, immunotherapy and cancer vaccines.

Ostrand-Rosenberg S. Ostrand-Rosenberg S. Curr Opin Immunol. 2004 Apr;16(2):143-50. doi: 10.1016/j.coi.2004.01.003. Curr Opin Immunol. 2004. PMID: 15023405 Review.

2

Gene dosage and antigenic expression on the cell surface of bovine erythrocytes.

Ostrand-Rosenberg S. Ostrand-Rosenberg S. Anim Blood Groups Biochem Genet. 1975;6(2):81-99. doi: 10.1111/j.1365-2052.1975.tb01355.x. Anim Blood Groups Biochem Genet. 1975. PMID: 56151

3

Invariant chain alters the malignant phenotype of MHC class II+ tumor cells.

Clements VK, Baskar S, Armstrong TD, Ostrand-Rosenberg S. Clements VK, et al. J Immunol. 1992 Oct 1;149(7):2391-6. J Immunol. 1992. PMID: 1527384

4

Influence of major histocompatibility complex class I, class II and TLA genes on tumor rejection.

Ostrand-Rosenberg S, Garcia EP, Roby CA, Clements VK. Ostrand-Rosenberg S, et al. Semin Cancer Biol. 1991 Oct;2(5):311-9. Semin Cancer Biol. 1991. PMID: 1773047 Review.

5

Rejection of allogeneic tumor is not determined by host responses to MHC class I molecules and is mediated by CD4-CD8+ T lymphocytes that are not lytic for the tumor.

Cole GA, Ostrand-Rosenberg S. Cole GA, et al. Cell Immunol. 1991 May;134(2):480-90. doi: 10.1016/0008-8749(91)90319-7. Cell Immunol. 1991. PMID: 1902400

6

Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes.

Ostrand-Rosenberg S, Roby C, Clements VK, Cole GA. Ostrand-Rosenberg S, et al. Int J Cancer Suppl. 1991;6:61-8. doi: 10.1002/ijc.2910470714. Int J Cancer Suppl. 1991. PMID: 1906055

7

Mouse Hepa-1 tumor is rejected by H-2Db-restricted CTL despite decreased MHC class I antigen expression.

Nishimura MI, Ostrand-Rosenberg S. Nishimura MI, et al. Cell Immunol. 1991 Sep;136(2):414-24. doi: 10.1016/0008-8749(91)90363-g. Cell Immunol. 1991. PMID: 1908353

8

Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule.

Ostrand-Rosenberg S, Roby CA, Clements VK. Ostrand-Rosenberg S, et al. J Immunol. 1991 Oct 1;147(7):2419-22. J Immunol. 1991. PMID: 1918972

9

Rejection of mouse sarcoma cells after transfection of MHC class II genes.

Ostrand-Rosenberg S, Thakur A, Clements V. Ostrand-Rosenberg S, et al. J Immunol. 1990 May 15;144(10):4068-71. J Immunol. 1990. PMID: 2332639

10

Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host.

Ostrand-Rosenberg S, Cole GA, Nishimura MI, Clements VK. Ostrand-Rosenberg S, et al. Cell Immunol. 1990 Jun;128(1):152-64. doi: 10.1016/0008-8749(90)90014-i. Cell Immunol. 1990. PMID: 2344619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results